Gilead Sciences Inc (NASDAQ:GILD)

101.12
Real-Time Quote
 -0.16 / -0.16%
Today’s Change
57.31
Today|||52-Week Range
102.57
+34.65%
Year-to-Date
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains ...
11:42am / Zacks.com
Strong Earnings Season Winding Down - Earnings Outlook
Aug 14 / Zacks.com
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
Aug 19 / Zacks.com
Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News
Aug 14 / Zacks.com
Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
Aug 19 / Zacks.com
Stock Market News for August 14, 2014 - Market News
Aug 14 / Zacks.com
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
Aug 19 / Zacks.com
Notable 52-Week Highs and Lows of the Day 8/13: (ITMN) (TSLA) (GILD) High; (SEAS) (KI...
Aug 13 / Investing Channel
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
Aug 19 / Zacks.com
Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Aug 13 / Zacks.com
PDL BioPharma Misses on Q2 Earnings due to Higher Expenses - Analyst Blog
Aug 19 / Zacks.com
BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog
Aug 13 / Zacks.com
Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session - Tale of the Tape
Aug 19 / Zacks.com
Signs of Leadership Returning
Aug 13 / TheStreet.com
Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog
Aug 18 / Zacks.com
Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog
Aug 13 / Zacks.com
Should Achillion Pharma (ACHN) Be In Your Portfolio Now? - Stocks in the News
Aug 18 / Zacks.com
Pharmacyclics Has Edge Over Blood Cancer Competitors
Aug 13 / TheStreet.com
Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog
Aug 18 / Zacks.com
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Aug 13 / Zacks.com
Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up - Analyst Blog
Aug 18 / Zacks.com
Gilead (GILD) Hits New Lifetime High Today
Aug 13 / TheStreet.com
Playing the New Hepatitis C Drugs
Aug 18 / TheStreet.com
Celladon (CLDN) Falls: Stock Goes Down 6.2% - Tale of the Tape
Aug 13 / Zacks.com
3 Big Stocks on Traders' Radars
Aug 18 / TheStreet.com
Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
Aug 12 / Zacks.com
#PreMarket Primer: Monday, August 18: Jackson Hole Draws Market Attention
Aug 18 / Benzinga
Tekmira Shares Continue to Rise in the Search for Ebola Cure - Analyst Blog
Aug 12 / Zacks.com
Markets Close The Week On Negative Note As Ukraine Worries Mount
Aug 15 / Benzinga
Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog
Aug 12 / Zacks.com
A Double Dose of Good News for Gilead Sciences, Inc.
Aug 15 / MotleyFool.com
What is Your Stock's Earnings Yield? - Screen of the Week
Aug 12 / Zacks.com
Notable 52-Week Highs and Lows of the Day 8/15: (ACHN) (GILD) (BITA) High; (BAA) (XIN...
Aug 15 / Investing Channel
Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog
Aug 12 / Zacks.com
Why Achillion Pharmaceuticals, Inc. Stock Soared
Aug 15 / MotleyFool.com
MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog
Aug 12 / Zacks.com
3 Drugs Stocks Moving The Industry Upward
Aug 15 / TheStreet.com
Supernus (SUPN) Posts Strong Earnings in Q2, Guidance Raised - Analyst Blog
Aug 12 / Zacks.com
Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss - Analyst Blog
Aug 15 / Zacks.com
Anacor's Q2 Loss Narrower than Expected, Kerydin in Focus - Analyst Blog
Aug 12 / Zacks.com
Gilead (GILD): Today's Pre-Market Leader Stock
Aug 15 / TheStreet.com
OvaScience (OVAS) Shows Strength: Stock Up 7% - Tale of the Tape
Aug 12 / Zacks.com
Analysts' Actions: Davita, Gilead, G&K Services, Omnivision, More
Aug 15 / TheStreet.com
Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
Aug 12 / Zacks.com
UK watchdog backs B#400 a day hepatitis C drug
Aug 14 / FT.com
Time to Focus on Gilead Sciences (GILD) for Strong Earnings Growth Potential - Tale ...
Aug 12 / Zacks.com
Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog
Aug 14 / Zacks.com
MannKind Enters into a Global Deal with Sanofi for Afrezza - Analyst Blog
Aug 11 / Zacks.com
Strong Earnings Season Winding Down - Earnings Trends
Aug 14 / Zacks.com
Tekmira Pharma Soars on FDA Announcement over Ebola Drug - Analyst Blog
Aug 11 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.